|
ARSB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.88630000000001E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.91870000004957E-06 |
| Normal-vs-Stage2 |
8.106000E-02 |
| Normal-vs-Stage3 |
1.377430E-03 |
| Normal-vs-Stage4 |
2.762200E-01 |
| Stage1-vs-Stage2 |
2.565400E-01 |
| Stage1-vs-Stage3 |
7.173200E-01 |
| Stage1-vs-Stage4 |
3.780100E-03 |
| Stage2-vs-Stage3 |
2.892600E-01 |
| Stage2-vs-Stage4 |
3.309600E-01 |
| Stage3-vs-Stage4 |
1.830430E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.17309999999138E-05 |
| Normal-vs-AfricanAmerican |
1.652190E-01 |
| Normal-vs-Asian |
3.570400E-01 |
| Caucasian-vs-AfricanAmerican |
1.993620E-01 |
| Caucasian-vs-Asian |
6.375800E-01 |
| AfricanAmerican-vs-Asian |
9.692400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.258620E-03 |
| Normal-vs-Female |
1.39030000001483E-06 |
| Male-vs-Female |
4.516500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.666200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.447600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.222590E-04 |
| Normal-vs-Age(81-100Yrs) |
1.253600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.981620E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.800600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.294410E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.375400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.136000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.779800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.444690E-03 |
| Normal-vs-Grade 2 |
3.53220000000043E-05 |
| Normal-vs-Grade 3 |
4.14720000000424E-05 |
| Normal-vs-Grade 4 |
3.041400E-01 |
| Grade 1-vs-Grade 2 |
3.176000E-01 |
| Grade 1-vs-Grade 3 |
3.632000E-01 |
| Grade 1-vs-Grade 4 |
1.246760E-01 |
| Grade 2-vs-Grade 3 |
9.199000E-01 |
| Grade 2-vs-Grade 4 |
2.518600E-01 |
| Grade 3-vs-Grade 4 |
2.385400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.335799579953E-10 |
| Normal-vs-ccB subtype |
5.249600E-02 |
| ccA subtype-vs-ccB subtype |
6.393600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.3276000000021E-05 |
| Normal-vs-N1 |
9.927200E-01 |
| N0-vs-N1 |
1.479160E-01 |
|
|
